Bowang Pharma
舶望制药
Bowang Pharma
Biotech/Healthcare
Argo Biopharma develops next-generation RNAi therapeutics. The company was founded by scientists who returned to China with extensive experience in RNAi drug development.
Latest round: Series A Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.